BeStock  
Stocks › Biotechnology › RPRX

Royalty Pharma RPRX

US equityMarket cap rank #641Biotechnology
$68.45 +$0.73 (+1.08%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $67.91 -0.79%
Open$68.17
Prev close$67.72
Day range$67.95 – $68.83
Volume3.53M
Market cap$30.48B
P/E (TTM)44.7
Dividend yield1.35%

Valuation

Multiples measured against the stock's own five-year history

Price / earnings44.7x
CheapRich

Near the top of its 5-year range · 84th percentile, 5-year average 42.1x

#2559 of 2996 stocks by PE (1 = cheapest)

Price / book4.5x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average 2.6x

#4370 of 5338 stocks by PB (1 = cheapest)

Price / sales11.6x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average 7.1x

#4605 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-56x97x250x403xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$67.00
Price vs. fair value+2.2%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyMedium
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.46 – 2.59 99% (pricier than usual) #4370 of 5338 (1 = cheapest)
PE 44.74 40.65 42.10 84% (pricier than usual) #2559 of 2996 (1 = cheapest)
PS 11.65 8.07 7.09 99% (pricier than usual) #4605 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on RPRX.

Sign in to join the discussion.

Scroll to Top